Erectile Dysfunction Market Future Prospects and Top Companies like Meda Pharmaceuticals,Coloplast, Global Life Technologies, Reflexonic, Augusta Medical

A recurrent inability of a man to reach and/or to maintain a penile erection sufficient for/during sexual activities is called erectile dysfunction. This medical condition of penis is most likely an age-related factor and a progressive condition that affects some level of disorder (mild, moderate or severe) in about 50% of men aged 40-70 years. Moreover, the severity of the condition increase with growing age with a ratio of about 5% at the age of 50 to 15% at 70 years. Age and secondary medical conditions such as dyslipedemia, diabetes, hypertension, cardiovascular diseases, and depression can be responsible for erectile dysfunction. However, only andrologists, urologists, and sex therapists dealt with the condition in the past. Currently, increasing development in the oral drug therapy for the treatment of erectile dysfunction and growing R&D related to the condition is contributing to growth of the market.

Increasing prevalence of erectile dysfunction is expected to boost growth of the market. For instance, according to a study conducted by Canadian Institute of Health Research, among 4,000 men between the age 40 and 88 years in Canada, 50% suffered from erectile dysfunction. Moreover, the study also revealed that the probability of the condition was two times more in men with cardiovascular diseases and four times more usual in men suffering with any kind of diabetes. Such scenario is expected to increasing demand for Cialis drugs, thereby propelling growth of the erectile dysfunction market.

Request A Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/200

The global erectile dysfunction market was valued at US$ 4,129.5 million in 2015 and is expected to witness a CAGR of 0.2% during the forecast period (2016 – 2024).

In the recent past, over 31 chemical moiety have advanced into the therapeutic pipeline and 90% of these drugs/molecules are developed by companies and 10% of the molecules/drugs are developed by medical universities and institutes. However, increasing number of molecules and drugs in clinical trials has failed to cater to increasing demand for effective treatment of erectile dysfunction in low income countries. This can be attributed to lack of regional presence of mid-level pharmaceutical companies.

Key players in the market are focused on adopting M&A strategies in order to expand their product portfolio. For instance, in 2014, Endo Pharmaceutical Holdings’ sale of American Medical Systems. In brief, some of the private equity firms are interested to buy American Medical Systems, which is one of the leading manufacturer of products used in the treatment of pelvic disorders of male and female, erectile dysfunction prostheses, and laser technology devices.

Get PDF Brochure of This Business Report: https://www.coherentmarketinsights.com/insight/request-pdf/200

According to pharma industry news, in 2012, Viagra drugs dominated the erectile dysfunction market with an approximate market share of about 45% in terms of revenue. The market value for Viagra has declined due to its patent expiry in European countries by 2013. However, some pharmaceutical companies are focused on introducing generic Viagra drug for the treatment of erectile dysfunction. The patent loss has not significantly affected the U.S. market as it has witnessed continuous growth and is expected to maintain its dominant position in the market by 2020.

Cialis accounts for the second largest market share worldwide. However, the segment is expected to witness decline in market share as the patent expiration is due in mid of 2017. Moreover, one of the Bayer’s erectile dysfunction drugs, Levitra/Staxyn is expected to lose its patent by 2018. This in turn is also expected to hinder the market growth over the forecast period. However, presence of around 50 drug molecules under clinical trials and their expected launch in 2018 and 2019 is expected to boost growth of the erectile dysfunction market.

In-Depth TOC with Percentage Discount @ https://www.coherentmarketinsights.com/insight/request-discount/200

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.